Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q3 FY23 results · Oct–Dec 2022
Amrutanjan Health Care reported revenue from operations of ₹97.65 crore (down 11.8% from Q3 FY22) and net profit of ₹10.71 crore (down 48.0% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a standalone basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 97.65 | 110.70 | −11.8% | 110.72 | −11.8% |
| Other income | 3.68 | 3.20 | +15.0% | 3.03 | +21.3% |
| Total income | 101.32 | 113.89 | −11.0% | 113.75 | −10.9% |
| Profit before tax | 14.50 | 27.91 | −48.0% | 17.42 | −16.7% |
| Net profit for the period | 10.71 | 20.58 | −48.0% | 12.77 | −16.1% |
| EPS, basic (₹) | 3.67 | 7.05 | −47.9% | 4.37 | −16.0% |
| Net margin (%) | 11.0 | 18.6 | 11.5 |
Standalone
- Filed with BSE
- 17 Feb 2023, 13:13 IST
- Board meeting
- 14 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE